04 Sep 2026
1 month ago
522 views
Associate Health Minister David Seymour welcomes Medsafe’s approval for two psychiatrists to prescribe pharmaceutical grade MDMA for treating PTSD through psychedelic-assisted therapy, aligning New Zealand with Australia’s clinical practices. MDMA remains unapproved as a medicine, but strict safeguards and comprehensive clinical assessments ensure its safe and appropriate use within a controlled therapeutic setting, with no take-home dispensing allowed. This approval is specific to the two psychiatrists, requiring other clinicians to obtain separate Medsafe authorization, reflecting a commitment to expanding access to innovative treatments responsibly.
14 Apr 2026
6 months ago
1075 views
New Zealand has significantly reduced medicinal cannabis export licensing times, with average processing dropping from 22.5 working days in 2022/2023 to 6.4 days in 2026, boosting export volumes and improving cashflow for exporters. The government is modernizing the licensing process by introducing electronic applications and considering more permanent licenses to reduce bureaucratic hurdles. Additionally, legislation changes now allow growers to cultivate low-THC hemp without a license, expanding opportunities in the medicinal cannabis industry.
01 Feb 2026
8 months ago
1326 views
New Zealand has expanded who can assess, diagnose, and start treatment for ADHD to improve timely access, allowing specialist GPs and nurse practitioners to manage adults and certain nurse practitioners to treat children under 18. Previously, only specialists could prescribe ADHD medicines, but now prescribing rules have been widened, removing prior restrictions and easing access to medication. These changes, along with removing renewal requirements for funded stimulant medicines, aim to connect more people with support earlier and positively impact education, employment, relationships, and mental health.
12 Nov 2025
11 months ago
1145 views
Associate Health Minister David Seymour welcomes the passing of the Medicines Amendment Bill, which introduces the 'Rule of Two' for faster approval of medicines with recognition from two overseas jurisdictions. The streamlined verification pathway aims to increase access to medicines for New Zealanders, starting with countries like Australia, the United States, and the United Kingdom. The government prioritizes improving patient outcomes by enhancing access to medicines through initiatives like increased Pharmac funding, patient input in funding decisions, and efficient regulatory processes.
19 Aug 2025
1 year ago
1650 views
Associate Health Minister David Seymour highlights that Medsafe has been improving its efficiency in approving new medicines, with significant reductions in evaluation timeframes for both innovative and generic medicines. The implementation of initiatives like the Rule of Two and leveraging AI technology are expected to further expedite the approval processes. The focus is on ensuring faster access to vital medications for New Zealanders, with a commitment to a regulatory system that prioritizes timely approval without compromising safety.
24 Jul 2025
1 year ago
2129 views
Associate Health Minister David Seymour supports the publication of guidelines by Medsafe for prescribing Psilocybin to treat depression, aligning New Zealand with Australia. The guidelines require practitioners to meet specific criteria, including registration with the Medical Council and expertise in psychedelic-assisted therapy. Approval allows experienced psychiatrists to prescribe Psilocybin to patients with treatment-resistant depression, with the potential for more practitioners to follow suit, expanding access to this treatment option.
01 Jul 2025
1 year ago
2151 views
Associate Health Minister David Seymour has empowered Pharmac and Medsafe to explore the utilisation of artificial intelligence (AI) to speed up their processes. “Faster access to medicines has always been a priority of mine. For many New Zealanders, pharmaceuticals are life or death, or the difference between a life of pain and suffering or living freely,” Mr Seymour says.
24 Jun 2025
1 year ago
2387 views
Minister for Mental Health Matt Doocey has welcomed prescribing changes that will enable GPs and nurse practitioners to diagnose and treat adults with Attention-Deficit Hyperactivity Disorder (ADHD). “I applaud Pharmac and Medsafe’s decision to widen prescribing rules for ADHD medicines from next February, this decision will give New Zealanders faster access to assessments and treatment,” Mr Doocey says. “This is a common-sense change that will make a meaningful difference in many lives of New Zealanders.
18 Jun 2025
1 year ago
2099 views
Associate Health Minister David Seymour says the Government is delivering on its promise to cut red tape and give Kiwis greater access to more treatments, starting with melatonin and medicinal psilocybin. “Many New Zealanders have asked me why people can buy melatonin overseas but they can’t buy it from their local pharmacy. Medsafe has assessed this and decided there’s no reason why it shouldn’t be available on pharmacy shelves right here at home,” says Mr Seymour.